Abstract:ABSTRACT BACKGROUND Hypertrophy cardiomyopathy (HCM) is the most common cardiac genetic disorder with the histopathological features of cardiomyocyte hypertrophy and cardiac fibrosis. The pathological remodeling that occurs in the myocardium of HCM patients may ultimately progress to heart failure and death. A thorough understanding of the cell type-specific changes in the pathological cardiac remodeling of HCM is crucial for developing successful medical therapies to prevent or mitigate the progression of this disease. METHODS We performed single-nucleus RNA-seq of the cardiac tissues from 10 HCM patients and 2 healthy donors, and conducted spatial transcriptomic assays of 4 cardiac tissue sections from 3 HCM patients. Comparative analyses were performed to explore the lineage-specific changes in expression profile, subpopulation composition and intercellular communication in the cardiac tissues of HCM patients. Based on the results of independent analyses including pseudotime ordering, differential expression analysis, and differential regulatory network analysis, we prioritized candidate therapeutic targets for mitigating the progression to heart failure or attenuating the cardiac fibrosis in HCM. Using the spatial transcriptomic data, we examined the spatial activity patterns of the key candidate genes, pathways and subpopulations. RESULTS Unbiased clustering of 55,122 nuclei from HCM and healthy conditions revealed 9 cell lineages and 28 clusters. Significant expansion of vascular-related lineages and contraction of cardiomyocytes, fibroblasts and myeloid cells in HCM were observed. The transcriptomic dynamics during the transition towards the failing state of cardiomyocytes in HCM were uncovered. Candidate target genes for mitigating the progression to heart failure in HCM were obtained such as FGF12 , IL31RA , BDNF , S100A1 , CRYAB and PROS1 . The transcriptomic dynamics underlying the fibroblast activation were also uncovered, and candidate targets for attenuating the cardiac fibrosis in HCM were obtained such as RUNX1 , MEOX1 , AEBP1 , LEF1 and NRXN3 . CONCLUSIONS We provided a comprehensive analysis of the lineage-specific regulatory changes in HCM. Our analysis identified a vast array of candidate therapeutic target genes and pathways to prevent or attenuate the pathological remodeling of HCM. Our datasets constitute a valuable resource to examine the lineage-specific expression changes of HCM at single-nucleus and spatial resolution. We developed a web-based interface ( http://snsthcm.fwgenetics.org/ ) for further exploration.

Machine learning modeling identifies hypertrophic cardiomyopathy subtypes with genetic signature

Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis

Deep Learning-Derived 12-Lead Electrocardiogram-Based Genotype Prediction for Hypertrophic Cardiomyopathy: a Pilot Study.

Pgpm_a_314880 823..837

Abstract 58: Modeling Pathogenesis in Familial Hypertrophic Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells

[Advances in the Molecular Pathogenesis of Hypertrophic Cardiomyopathy].

Genetic Dissection of Hypertrophic Cardiomyopathy with Myocardial RNA-Seq

Machine learning‐driven diagnostic signature provides new insights in clinical management of hypertrophic cardiomyopathy

Subtypes and Mechanisms of Hypertrophic Cardiomyopathy Proposed by Machine Learning Algorithms

A personalized mRNA signature for predicting hypertrophic cardiomyopathy applying machine learning methods

Machine Learning in Hypertrophic Cardiomyopathy: Nonlinear Model From Clinical and CMR Features Predicting Cardiovascular Events

Integration of Transcriptomic Data Identifies Key Hallmark Genes in Hypertrophic Cardiomyopathy

Gene-echocardiography: Refining Genotype-Phenotype Correlations in Hypertrophic Cardiomyopathy

Investigation of Pathogenic Genes in Chinese Sporadic Hypertrophic Cardiomyopathy Patients by Whole Exome Sequencing.

Lineage-specific regulatory changes in hypertrophic cardiomyopathy unraveled by single-nucleus RNA-seq and spatial transcriptomics

[Mutation and Clinical Relevance in a Large Cohort of Unrelated Chinese Patients with Hypertrophic Cardiomyopathy].

A Research on the Relationship of Genotypes and Phenotypes in Hypertrophic Cardiomyopathy

Abstract 11879: the Genetic Characteristics Based on Next Generation Sequencing in Patients with Hypertrophic Cardiomyopathy

Lineage-specific regulatory changes in the pathological cardiac remodeling of hypertrophy cardiomyopathy unraveled by single-nucleus RNA-seq and spatial transcriptomics

Preliminary Exploration of Genotype-Phenotype Correlation in Chinese with Hypertrophic Cardiomyopathy

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy